Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Accéder directement au contenu
Article Dans Une Revue Cytotherapy Année : 2018

Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy

Résumé

Exogenous human herpes virus 6 (HHV-6) reinfection has never been reported in patients receiving tumor-infiltrating T lymphocytes therapy. We report an unusual case of HHV-6 infection following infusion of HHV-6 infected autologous T lymphocytes. HHV-6 infection could interfere with the tumor antigen immune recognition and the efficacy of immunotherapy.
Fichier non déposé

Dates et versions

hal-02059880 , version 1 (07-03-2019)

Identifiants

Citer

Anastasiia Filippova, Julie Charles, Olivier Epaulard, Raphaële Germi, Virginie Persoons, et al.. Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy. Cytotherapy, 2018, 20 (4), pp.521-523. ⟨10.1016/j.jcyt.2017.12.006⟩. ⟨hal-02059880⟩
58 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More